999 research outputs found
The nature stroke study; NASTRU: A randomized controlled trial of nature-based post-stroke fatigue rehabilitation
Objective: To determine whether nature-based rehabilitation, as an add-on to standard care, has a long-term influence on post-stroke fatigue, perceived value of everyday occupations, disability, health-related quality of life, anxiety, and depression at follow-up 8 and 14 months after randomization.
Design: Single-blinded, 2-armed, randomized controlled trial.
Methods: Stroke survivors, identified through routine 3-month follow-up visit (sub-acute) or medical records (chronic stroke >1 year previously), were randomized to standard care + nature-based rehabilitation (intervention group) or standard care alone (control group). Blinded evaluations were conducted at follow-up 8 and 14 months after randomization, for the following outcomes: post-stroke fatigue (Mental Fatigue Scale; MFS), perceived value of everyday occupations (Occupational value instrument with predefined items), disability (modified Rankin Scale; mRS), health-related quality of life (Euro-QoL-5 Demension Questionnaire), anxiety (Hospital Anxiety and Depression Scale; HAD) and depression (HAD).
Results: Approximately one-quarter of the screened patients were eligible for inclusion in the study; of these, half agreed to participate; a final total of 101 patients were randomized (mean age 67 years, 60% female). The patients with sub-acute stroke were highly compliant with the intervention. The participants in both the intervention and control groups improved, However, no statistically significant differences in improvement were found between the intervention and control groups for any of the outcome measures. Fatigue decreased to a value below the suggested cut-off for mental fatigue (<10.5) in the intervention group, but not in the control group.
Conclusion: Nature-based rehabilitation is feasible and well tolerated. A larger randomized controlled trial is warranted
European Stroke Science Workshop
The European Stroke Organisation held its first European Stroke Science Workshop in Garmisch-Partenkirchen, Germany (December 15-17, 2011). Stroke experts based in Europe were invited to present and discuss their current research. The scope of the workshop was to review the most recent findings of selected topics in stroke, to exchange ideas, to stimulate new research, and to enhance collaboration between European stroke research groups. Seven scientific sessions were held, each starting with a keynote lecture to review the state of the art of the given topic, followed by 4 or 5 short presentations by experts. They were asked to limit their presentations to 10 slides containing only recent information. The meeting was organized by the executive committee of the European Stroke Organisation (Heinrich Mattle, chairman, Michael Brainin, Angel Chamorro, Werner Hacke, Didier Leys) and supported by the European Stroke Conference (Michael Hennerici). The following sections summarize the content of the workshop. Copyright (c) 2012 S. Karger AG, Base
results of the sifap1 study
Objectives The present study aimed to evaluate the frequency of warning signs
in younger patients with stroke with a special regard to the ‘FAST’ scheme, a
public stroke recognition instrument (face, arm, speech, timely). Setting
Primary stroke care in participating centres of a multinational European
prospective cross-sectional study (Stroke in Young Fabry Patients; sifap1).
Forty-seven centres from 15 European countries participate in sifap1.
Participants 5023 acute patients with stroke (aged 18–55 years) patients
(96.5% Caucasians) were enrolled in the study between April 2007 and January
2010. Primary and secondary outcome measures sifap1 was originally designed to
investigate the relation of juvenile stroke and Fabry disease. A secondary aim
of sifap1 was to investigate stroke patterns in this specific group of
patients. The present investigation is a secondary analysis addressing stroke
presenting symptoms with a special regard to signs included in the FAST
scheme. Results 4535 patients with transient ischaemic attack (TIA; n=1071),
ischaemic stroke (n=3396) or other (n=68) were considered in the presented
analysis. FAST symptoms could be traced in 76.5% of all cases. 35% of those
with at least one FAST symptom had all three symptoms. At least one FAST
symptom could be recognised in 69.1% of 18–24 years-old patients, in 74% of
those aged 25–34 years, in 75.4% of those aged 35–44 years, and 77.8% in 45–55
years-old patients. With increasing stroke severity signs included in the FAST
scheme were more prevalent (National Institute of Health Stroke Scale,
NIHSS15: 100%). Clustering clinical signs
according to FAST lower percentages of strokes in the posterior circulation
(65.2%) and in patients with TIA (62.3%) were identified. Conclusions FAST may
be applied as a useful and rapid tool to identify stroke symptoms in young
individuals aged 18–55 years. Especially in patients eligible for thrombolysis
FAST might address the majority of individuals
Development of a poststroke checklist to standardize follow-up care for stroke survivors
Background: Long-termcare for stroke survivors is fragmented and lacks an evidence-based, easy-to-use tool to identify persistent long-term problems among stroke survivors and streamline referral for treatment. We sought to develop a poststroke checklist (PSC) to help health care professionals identify poststroke problems amenable to treatment and subsequent referral. Methods: An instrument development team, supported by measurement experts, international stroke experts, and poststroke care stakeholders, was created to develop a long-term PSC. A list of long-term poststroke problem areas was generated by an international, multidisciplinary group of stroke experts, the Global Stroke Community Advisory Panel. Using Delphi methods, a consensus was reached on which problem areas on the list were most important and relevant to include in a PSC. The instrument development team concurrently created the actual checklist, which provided example language about how to ask about poststroke problem areas and linked patient responses to a specific referral process.
Results: Eleven long-term poststroke problem areas were rated highly and consistently among stroke experts participating in the Delphi process (n = 12): secondary prevention, activities of daily living, mobility, spasticity, pain, incontinence, communication, mood, cognition, life after stroke, and relationship with caregiver. These problem areas were included in the long-term PSC.
Conclusions: The PSC was developed to be a brief and easy-to-use tool, intended to facilitate a standardized approach for health care providers to identify long-term problems in stroke survivors and to facilitate appropriate referrals for treatment
Dizziness Presentations in U.S. Emergency Departments, 1995–2004
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71563/1/j.1553-2712.2008.00189.x.pd
Kvalitetsregistret Riksstroke visar på ojämlik strokevård. : Omedveten diskriminering kanske förklarar en del av skillnaderna.
In this article, results from a series of studies on the relationships between socioeconomic factors and stroke processes (stroke unit care, acute reperfusion treatment, secondary prevention with oral anticoagulants and statins) and outcomes (long-term survival, return to work and risk of suicide and suicide attempts) are summarized. The overall pattern is that acute and secondary prevention interventions and prognosis are better in patients with a high compared with a low level of education, better in people with high than low income, better in people who are cohabitant than single. As to country of birth, a more complex pattern has emerged. Unmeasured confounding may possibly explain part of the difference, but the socioeconomic gradients remain after adjustment for multiple potential confounders, leaving the possibility that there is an element of unconscious discrimination in stroke care
Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century
Opalski's Syndrome with Cerebellar Infarction
A 64-year-old man presented with sudden onset of right-sided hemiparesis, headache, gait disturbance, and recurrent vomiting. A physical examination revealed right-sided hemiparesis, right Horner syndrome, ataxia of the right limbs, and diminished sensation on the left side of his body. Diffusion-weighted MRI revealed an acute right lateral medullary infarction extending from the rostral medulla to the upper cervical cord, and an acute cerebellar infarction in the territory of the medial branch of the posterior inferior cerebellar artery. Magnetic resonance angiography revealed suspicious severe stenosis or near occlusion of the proximal and distal parts of the right vertebral artery, and hypoplasia of the left vertebral artery. We diagnosed ipsilateral hemiparesis with lateral medullary infarction (Opalski's syndrome) and concomitant cerebellar infarction
What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
Cheiro-Oral Syndrome: A Clinical Analysis and Review of Literature
Purpose: After a century, cheiro-oral syndrome (COS) was harangued and emphasized for its localizing value and benign course in recent two decades. However, an expanding body of case series challenged when COS may arise from an involvement of ascending sensory pathways between cortex and pons and terminate into poor outcome occasionally. Materials and Methods: To analyze the location, underlying etiologies and prognosis in 76 patients presented with COS collected between 1989 and 2007. Results: Four types of COS were categorized, namely unilateral (71.1%), typically bilateral (14.5%), atypically bilateral (7.9%) and crossed COS (6.5%). The most common site of COS occurrence was at pons (27.6%), following by thalamus (21.1%) and cortex (15.8%). Stroke with small infarctions or hemorrhage was the leading cause. Paroxysmal paresthesia was predicted for cortical involvement and bilateral paresthesia for pontine involvement, whereas crossed paresthesia for medullary involvement. However, the majority of lesions cannot be localized by clinical symptoms alone, and were demonstrated only by neuroimaging. Deterioration was ensued in 12 % of patients, whose lesions were large cortical infarction, medullary infarction, and bilateral subdural hemorrhage. Conclusion: COS arises from varied sites between medulla and cortex, and is usually caused by small stroke lesion. Neurological deterioration occurs in 12 % of patients and relates to large vessel occlusion, medullary involvement or cortical stroke. Since the location and deterioration of COS cannot be predicted by clinical symptoms alone, COS should be considered an emergent condition for aggressive investigation until fatal cause is substantially excluded
- …